Evidence map›Paper›PMID 31082342›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].

L M Sun, H P Yan, J L Lou, Y Wang, Y Zhao, Y H Yu, H P Zhang, Y M Liu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

L M SunCenter for Clinical Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
H P YanCenter for Clinical Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
J L LouCenter for Clinical Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y WangDepartment of Liver Disease Immunology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y ZhaoCenter for Clinical Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y H YuCenter for Clinical Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
H P ZhangCenter for Clinical Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y M LiuDepartment of Liver Disease Immunology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Capital Medical University · CNBeijing YouAn Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemical and Drug Induced Liver InjuryAutoantibodiesEnzyme-Linked Immunosorbent AssayHumansLiverLiver Cirrhosis, BiliaryRetrospective StudiesAutoantibodiesAnti-mitochondrial M2 subtypesDrug-induced liver injuryPrimary biliary cholangitis

Identifiers

PMID31082342
PMCPMC12769216
OpenAlexW3012800704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.